SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000899140-18-000279
Filing Date
2018-03-08
Accepted
2018-03-08 17:29:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D i23988949a.htm SC 13D 56685
2 VOTING TRUST AGREEMENT i23988949b.htm EX-99.1 235560
  Complete submission text file 0000899140-18-000279.txt   293874
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Subject) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87828 | Film No.: 18677547
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BESSEMER TRUST CO. OF DELAWARE, N.A. 1007 NORTH ORANGE STREET, SUITE 1450 WILMINGTON DE 19801
Business Address C/O BESSEMER TRUST CO. OF DELAWARE, N.A. 1007 NORTH ORANGE STREET, SUITE 1450 WILMINGTON DE 19801 302 230 2675
Insys Therapeutics, Inc. Voting Trust (Filed by) CIK: 0001733779 (see all company filings)

IRS No.: 357199139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D